What does Revelation Biosciences, Inc. do?

Jun 22 2025 07:14 PM IST
share
Share Via
Revelation Biosciences, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $2 million and a market cap of $1.60 million. Key metrics include a negative P/E ratio, no dividend yield, and a debt-to-equity ratio of -1.29.
Overview:
Revelation Biosciences, Inc. operates in the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company. Financial Snapshot: Net Profit: -2 Million (Quarterly Results - Mar 2025) Market Cap: USD 1.60 Million (Micro Cap) Key Metrics: P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: -1.29 Return on Equity: -500.65% Price to Book: 0.56 Contact Details: Details: No Company Details Available Registrar Address: Not available.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Revelation Biosciences, Inc. overvalued or undervalued?
Jun 25 2025 09:30 AM IST
share
Share Via
How big is Revelation Biosciences, Inc.?
Jun 22 2025 06:24 PM IST
share
Share Via